Type 2 immunity in homeostasis and disease (3rd edition)
Following the success of the previous editions, VIB is proud to welcome you back to Ghent for the 3rd edition of Type 2 immunity in homeostasis and disease. Set against the stunning backdrop of the Bijloke —a 13th-century architectural treasure— this 2026 conference promises to be a vital meeting point for the international immunology community.
This year’s program brings together world-leading experts and rising voices to explore the latest insights into type 2 immunity beyond its classical boundaries. Across five focused sessions, we’ll dive into:
- Effector mechanisms in homeostasis, repair, and dysregulation
- Interacting cell types and tissue niches
- Neuro/endocrine crosstalk
- Pathology and allergic disease
- Infectious disease, cancer, and fibrosis
As therapeutic strategies increasingly target type 2 pathways, understanding the full spectrum of their roles has never been more urgent. Join us to engage with cutting-edge science, foster collaboration, and help shape the future of immune-driven therapies.
Confirmed speakers include:
- Xingbin Ai, Harvard Medical School, US
- Isabelle Arnold, University of Zurich, CH
- David Artis, Weill Cornell Medicine, US
- Nora Barrett, Brigham and Women's Hospital, US
- Daniel Dwyer, Harvard Medical School, US
- Nicolas Gaudenzio, Inserm - INFINITY, FR
- Tim Halim, Cambridge University, UK
- Bart Lambrecht, VIB-UGent Center for Inflammation Research, BE
- Beatriz Léon, NIH, US
- Clare Lloyd, Imperial College London, UK
- Bénédicte Machiels, University of Liège, BE
- Jenny Mjösberg, Karolinska Institutet, SE
- Anna Molofsky, University of California-San Francisco, US
- Ari Molofsky, University of California, San Francisco, US
- Arthur Mortha, University of Toronto, CA
- Christoph Schneider, University of Zürich, CH
- Feng Shao, National Institute of Biological Sciences, CN
- Dean Sheppard, University of California, US
- Carrie Sokol, Harvard Medical School, US
- Philipp Starkl, Medical University of Vienna, AT
Deadlines:
- Abstract deadline: 8 January 2026
- Early bird deadline: 26 January 2026
- Final deadline: 23 February 2026